The study's objective is to come up with a description of the international financial ecosystem surrounding the development of novel medicines (R&D). This entails charting the types of public and private players involved in research and development of medicines, ascertaining how the research agenda is prepared, establishing the strategies, mechanisms, incentives and drivers of the actors, including investors, as well as how national and international funding for new medicines (including investments and disinvestments, returns, etc.) is shaped.
Tjenester
27.08.2020 10:00:00
73000000-2 Forsknings- og utviklingsvirksomhet og tilhørende konsulenttjenester
73110000-6 Forskning
73200000-4 Konsulentvirksomhet i forbindelse med forskning og utvikling
79311400-1 Økonomisk undersøkelse
71620000-0 Analysetjenester
66170000-2 Tjenester i forbindelse med finansrådgivning, finansoverføringshåndtering og finans/garanti-institusjon
| Kunngjøring | Dato for oversendelse |
|---|---|
| [TNV3F02ContractNotice] (TenderNed) | 29.04.2020 16:00 |
[TNV3F14Corrigendum] (TenderNed)
|
24.06.2020 13:23 |
| [TNV3F03ContractAwardNotice] (TenderNed) | 21.07.2021 16:30 |